Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Conference item |
Publicerad: |
American Society of Hematology
2017
|